Healy James's Form 4 filing
Rapport Therapeutics, Inc. (RAPP) · filed Jun 10, 2024
- Accession no.
- 0000950170-24-071532
- Filed
- Jun 10, 2024
- Trade date
- Jun 10, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market purchases total $9.50M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Healy JamesCIK 0001245624 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | Common Stock | CConversionAcquired | +1,392,738 | $0.00 | $0 | 1,392,738 | Indirect | |
| Jun 10, 2024 | Common Stock | PPurchaseAcquired | +470,589 | $17.00 | +$8,000,013 | 1,863,327 | Indirect | |
| Jun 10, 2024 | Common Stock | PPurchaseAcquired | +18,641 | $17.00 | +$316,897 | 18,641 | Indirect | |
| Jun 10, 2024 | Common Stock | PPurchaseAcquired | +17,861 | $17.00 | +$303,637 | 17,861 | Indirect | |
| Jun 10, 2024 | Common Stock | PPurchaseAcquired | +26,278 | $17.00 | +$446,726 | 26,278 | Indirect | |
| Jun 10, 2024 | Common Stock | PPurchaseAcquired | +25,455 | $17.00 | +$432,735 | 25,455 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | Common Stock | CConversionDisposed | −1,392,738 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.